HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anne W M Lee Selected Research

Chemoradiotherapy

1/2022Exploratory Study of NPC-0501 Trial: Optimal Cisplatin Dose of Concurrent and Induction/Adjuvant Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma.
1/2021Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline.
1/2020NPC-0501 trial on the value of changing chemoradiotherapy sequence, replacing 5-fluorouracil with capecitabine, and altering fractionation for patients with advanced nasopharyngeal carcinoma.
1/2018Prospective, Multicenter, Phase 2 Trial of Induction Chemotherapy Followed by Bio-Chemoradiotherapy for Locally Advanced Recurrent Nasopharyngeal Carcinoma.
11/2017A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity.
1/2017Reporting Quality of Randomized, Controlled Trials Evaluating Combined Chemoradiotherapy in Nasopharyngeal Carcinoma.
1/2016Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review.
4/2015Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma.
4/2009Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.
3/2009Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anne W M Lee Research Topics

Disease

52Nasopharyngeal Carcinoma
10/2022 - 05/2002
28Neoplasms (Cancer)
01/2022 - 07/2003
10Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
12/2021 - 10/2005
5Head and Neck Neoplasms (Head and Neck Cancer)
03/2022 - 01/2016
4Neoplasm Metastasis (Metastasis)
01/2021 - 02/2012
3Carcinoma (Carcinomatosis)
01/2022 - 07/2012
2Epstein-Barr Virus Infections
01/2019 - 09/2012
2Hearing Loss (Hearing Impairment)
01/2018 - 03/2014
2Squamous Cell Carcinoma of Head and Neck
01/2016 - 01/2015
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2012 - 11/2011
2AIDS-Related Complex (ARC)
01/2012 - 11/2011
2Breast Neoplasms (Breast Cancer)
04/2008 - 07/2007
1Hypothyroidism
03/2022
1Hepatitis B
12/2020
1Extranodal Extension
12/2020
1Second Primary Neoplasms (Neoplasms, Second)
12/2020
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2020
1Paralysis (Palsy)
01/2019
1Hypoglossal Nerve Diseases
01/2019
1Stomatognathic Diseases (Dental Disease)
12/2018
1Atherosclerosis
01/2018
1Carotid Stenosis (Carotid Artery Stenosis)
01/2018
1Epistaxis (Nosebleed)
01/2018
1Necrosis
01/2017
1Disease Progression
04/2015
1Neutropenia
04/2015
1Cranial Nerve Diseases (Cranial Nerve Disorders)
01/2013
1Lung Neoplasms (Lung Cancer)
10/2012
1Genetic Predisposition to Disease (Genetic Predisposition)
09/2012
1Liver Neoplasms (Liver Cancer)
01/2012
1Prostatic Neoplasms (Prostate Cancer)
01/2012
1Arthrogryposis renal dysfunction cholestasis syndrome
11/2011
1Colorectal Neoplasms (Colorectal Cancer)
07/2011
1Margins of Excision
03/2011
1Sensorineural Hearing Loss
04/2009
1Deafness (Deaf Mutism)
03/2009

Drug/Important Bio-Agent (IBA)

10Cisplatin (Platino)FDA LinkGeneric
01/2022 - 08/2010
4DNA (Deoxyribonucleic Acid)IBA
10/2022 - 08/2005
4Capecitabine (Xeloda)FDA Link
01/2022 - 07/2011
4Fluorouracil (Carac)FDA LinkGeneric
01/2020 - 08/2010
3Biomarkers (Surrogate Marker)IBA
01/2017 - 07/2012
2Biological ProductsIBA
01/2018 - 01/2017
1B7-H1 AntigenIBA
01/2019
1Immune Checkpoint InhibitorsIBA
01/2019
1Docetaxel (Taxotere)FDA Link
01/2018
1Cetuximab (Erbitux)FDA Link
01/2018
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
11/2016
1Pharmaceutical PreparationsIBA
10/2015
1ElectrolytesIBA
04/2015
12-MethoxyestradiolIBA
12/2012
1Environmental CarcinogensIBA
09/2012
1Ethiodized Oil (Ethiodol)FDA Link
01/2012
1XELOXIBA
07/2011
1Leucovorin (Folinic Acid)FDA Link
07/2011
1Oxaliplatin (Eloxatin)FDA LinkGeneric
07/2011
1Proteins (Proteins, Gene)FDA Link
04/2011
1human ERBB2 proteinIBA
04/2008
1antineoplaston A10 (A 10)IBA
04/2006

Therapy/Procedure

48Radiotherapy
03/2022 - 05/2002
19Drug Therapy (Chemotherapy)
10/2022 - 10/2005
14Chemoradiotherapy
01/2022 - 10/2005
12Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
12/2020 - 02/2011
8Adjuvant Chemotherapy
01/2022 - 08/2010
6Therapeutics
01/2018 - 04/2011
5Induction Chemotherapy
01/2022 - 05/2008
5Re-Irradiation
01/2021 - 01/2015
5Conformal Radiotherapy
01/2012 - 05/2004
1Terminal Care (Care, Terminal)
11/2020
1Palliative Care (Palliative Therapy)
11/2020
1Immunotherapy
01/2019
1Adjuvant Chemoradiotherapy
11/2017
1Combination Drug Therapy (Combination Chemotherapy)
12/2015
1Aftercare (After-Treatment)
04/2009
1Segmental Mastectomy (Lumpectomy)
07/2007
1Salvage Therapy
05/2005